patient
CP
decision
square
method
2021
rizqi
value
septiani
indonesia
sample
favipiravir
december
covid
two
study
universita
selecting
pharmacoeconomic
length
calculation
out
reached
making
compared
purpose
effect
therapeutic
MICPS2
test
but
PCR
more
faculty
hematology
cohort
pharmacology
hospital
used
author
technique
effectivenes
umi
average
keyword
faster
find
significant
laboratory
stay
using
statistical
routine
ACER
independent
biopharmacy
ICER
therapy
corresponding
ratio
005
antiviral
putri
showed
muslim
research
show
kamri
indicate
population
use
described
between
hospitalized
drug
result
sampling
benefit
taken
blood
maulana
term
lolo
their
andi
design
city
analysi
LOS
also
day
parameter
ABSTRACT
collection
dadi
while
004
therapie
basri
september
retrospective
makassar
found
effective
than
purposive
there
nur
cost
azizah
difference
pharmacy
oseltamivir
people
being
evaluate
data
total
chi